Citations (89)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Akira Harada, Koichi Kurahara, Tomohiko Moriyama, Takahide Tanaka, Yutaka Nagata, Keisuke Kawasaki, Hiroki Yaita, Yuji Maehata, Junji Umeno, Yumi Oshiro, Tadahiko Fuchigami, Takanari Kitazono, Motohiro Esaki & Takayuki Matsumoto. (2019) Risk factors for reflux esophagitis after eradication of Helicobacter pylori. Scandinavian Journal of Gastroenterology 54:10, pages 1183-1188.
Read now
Read now
Fabrizio R. Parente, Stefano A. Bargiggia & Andrea Anderloni. (2006) Helicobacter pylori infection and antisecretory efficacy of proton-pump inhibitors in gastroesophageal reflux disease: A liaison dangereuse or an innocent interplay?. Scandinavian Journal of Gastroenterology 41:10, pages 1121-1125.
Read now
Read now
D. Y. Graham. (2000) NSAID ulcers: prevalence and prevention. Modern Rheumatology 10:1, pages 2-7.
Read now
Read now
Gianni Testing & Raffaella Testing. (1997) Helicobacter pylori and Maximal Acid Output in Chronic Gastritis. Scandinavian Journal of Gastroenterology 32:12, pages 1275-1276.
Read now
Read now
Articles from other publishers (85)
Ian C Roberts‐Thomson. (2021)
How did the ancient bacterium,
Helicobacter pylori
, cause an epidemic of chronic duodenal ulceration?
. JGH Open 5:6, pages 636-642.
Crossref
Crossref
Yon Ho Choe. 2016. Helicobacter pylori. Helicobacter pylori
331
341
.
Kentaro Sugano, Jan Tack, Ernst J Kuipers, David Y Graham, Emad M El-Omar, Soichiro Miura, Ken Haruma, Masahiro Asaka, Naomi Uemura & Peter Malfertheiner. (2015)
Kyoto global consensus report on
Helicobacter pylori
gastritis
. Gut 64:9, pages 1353-1367.
Crossref
Crossref
Marino Venerito & Peter Malfertheiner. (2015) Preneoplastic Conditions in the Stomach: Always a Point of No Return. Digestive Diseases 33:1, pages 5-10.
Crossref
Crossref
Akiko Shiotani, Putao Cen & David Y. Graham. (2013) Eradication of gastric cancer is now both possible and practical. Seminars in Cancer Biology 23:6, pages 492-501.
Crossref
Crossref
Werner Schwizer, Dieter Menne, Kurt Schütze, Michael Vieth, Reiner Goergens, Peter Malfertheiner, Andreas Leodolter, Michael Fried & Mark R Fox. (2013)
The effect of
Helicobacter pylori
infection and eradication in patients with gastro‐oesophageal reflux disease: A parallel‐group, double‐blind, placebo‐controlled multicentre study
. United European Gastroenterology Journal 1:4, pages 226-235.
Crossref
Crossref
Maria Pina Dore & David Y. Graham. 2013. Practical Manual of Gastroesophageal Reflux Disease. Practical Manual of Gastroesophageal Reflux Disease
267
285
.
K. Iijima, T. Koike, Y. Abe, H. Yamagishi, N. Ara, K. Asanuma, K. Uno, A. Imatani, N. Nakaya, S. Ohara & T. Shimosegawa. (2009) Gastric Hyposecretion in Esophageal Squamous-Cell Carcinomas. Digestive Diseases and Sciences 55:5, pages 1349-1355.
Crossref
Crossref
Huang-Ming Hu, Chao-Hung Kuo, Chien-Hung Lee, I-Chen Wu, Ka-Wo Lee, Jang-Ming Lee, Yih-Gang Goan, Shah-Hwa Chou, Ein-Long Kao, Ming-Tsang Wu & Deng-Chyang Wu. (2009) Polymorphism in COX-2 modifies the inverse association between Helicobacter pyloriseropositivity and esophageal squamous cell carcinoma risk in Taiwan: a case control study. BMC Gastroenterology 9:1.
Crossref
Crossref
Tomoyuki Akiyama, Masahiko Inamori, Hiroshi Iida, Hiroki Endo, Kunihiro Hosono, Kyoko Yoneda, Koji Fujita, Masato Yoneda, Hirokazu Takahashi, Ayumu Goto, Yasunobu Abe, Hiroyuki Kirikoshi, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Yasushi Rino & Atsushi Nakajima. (2009) Macroscopic extent of gastric mucosal atrophy: increased risk factor for esophageal squamous cell carcinoma in Japan. BMC Gastroenterology 9:1.
Crossref
Crossref
C. NICHITA, A. E.-W. ABDOU, P. MAERTEN, M. HERRANZ, N. MOURET, C. THALMANN, P. F. MICHETTI & G. DORTA. (2009) A single dose of intravenous esomeprazole decreases gastric secretion in healthy volunteers. Alimentary Pharmacology & Therapeutics 30:10, pages 1022-1029.
Crossref
Crossref
Marco Lazzaroni & Gabriele Bianchi Porro. (2009) Management of NSAID-Induced Gastrointestinal Toxicity. Drugs 69:1, pages 51-69.
Crossref
Crossref
Katsunori Iijima, Tomoyuki Koike, Hitoshi Sekine, Yasuhiko Abe, Kiyotaka Asanuma, Nobuyuki Ara, Kaname Uno, Akira Imatani, Shuichi Ohara & Tooru Shimosegawa. (2009) Sustained epithelial proliferation in a functionally irreversible fundic mucosa after Helicobacter pylori eradication. Journal of Gastroenterology 44:1, pages 47-55.
Crossref
Crossref
D.Y. Graham, M. Kato & M. Asaka. (2008) Gastric endoscopy in the 21st century: Appropriate use of an invasive procedure in the era of non-invasive testing. Digestive and Liver Disease 40:7, pages 497-503.
Crossref
Crossref
Mitchell L. Schubert & David A. Peura. (2008) Control of Gastric Acid Secretion in Health and Disease. Gastroenterology 134:7, pages 1842-1860.
Crossref
Crossref
Akiko Shiotani, Noriya Uedo, Hiroyasu Iishi, Masaharu Tatsuta, Shingo Ishiguro, Yukinori Nakae, Tomoari Kamada, Ken Haruma & Juanita L. Merchant. (2007)
Re‐expression of sonic hedgehog and reduction of CDX2 after
Helicobacter pylori
eradication prior to incomplete intestinal metaplasia
. International Journal of Cancer 121:6, pages 1182-1189.
Crossref
Crossref
David Y. Graham, Akiko Shiotani & Hala M.T. El-Zimaity. (2006) Chromoendoscopy points the way to understanding recovery of gastric function after Helicobacter pylori eradication. Gastrointestinal Endoscopy 64:5, pages 686-690.
Crossref
Crossref
Hitoshi Sekine, Katsunori Iijima, Tomoyuki Koike, Yasuhiko Abe, Akira Imatani, Katsuaki Kato, Suichi Ohara & Tooru Shimosegawa. (2006) Regional differences in the recovery of gastric acid secretion after Helicobacter pylori eradication: evaluations with Congo red chromoendoscopy. Gastrointestinal Endoscopy 64:5, pages 678-685.
Crossref
Crossref
Francesco Di Mario, Lucas Giovanni Cavallaro, Ali Mahamat Moussa, Pietro Caruana, Roberta Merli, Andrea Maini, Simone Bertolini, Nadia Dal Bó, Massimo Rugge, Giulia Martina Cavestro, Giovanni Aragona, Mario Plebani, Angelo Franzé & Giorgio Nervi. (2006) Usefulness of Serum Pepsinogens in Helicobacter pylori Chronic Gastritis: Relationship With Inflammation, Activity, and Density of the Bacterium. Digestive Diseases and Sciences 51:10, pages 1791-1795.
Crossref
Crossref
Amnon Sonnenberg. (2006) Causes underlying the birth-cohort phenomenon of peptic ulcer: analysis of mortality data 1911–2000, England and Wales. International Journal of Epidemiology 35:4, pages 1090-1097.
Crossref
Crossref
KAZUNARI MURAKAMI, RYUGO SATO, TADAYOSHI OKIMOTO, KOICHIRO WATANABE, MASARU NASU, MASAAKI KODAMA & TOSHIO FUJIOKA. (2006) Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial. Journal of Gastroenterology and Hepatology 21:6, pages 1048-1053.
Crossref
Crossref
Dilip Mahalanabis, M. Aminul Islam, Saijuddin Shaikh, Monilal Chakrabarty, Anura V. Kurpad, Swagata Mukherjee, Bandana Sen, M. Abu Khaled & Sten H. Vermund. (2007)
Haematological response to iron supplementation is reduced in children with asymptomatic
Helicobacter pylori
infection
. British Journal of Nutrition 94:6, pages 969-975.
Crossref
Crossref
Tomohiko Shimatani, Masaki Inoue, Keiko Iwamoto, Hideyuki Hyogo, Michiya Yokozaki, Toshinari Saeki, Susumu Tazuma, Yoko Horikawa & Nobue Harada. (2005) Gastric Acidity in Patients with Follicular Gastritis is Significantly Reduced, but Can be Normalized After Eradication for Helicobacter pylori. Helicobacter 10:3, pages 256-265.
Crossref
Crossref
H. Osawa, H. Kita, H. Ohnishi, H. Mutoh, Y. Ishino, K. Satoh & K. Sugano. (2005) Histamine-2 receptor expression in gastric mucosa before and after Helicobacter pylori cure. Alimentary Pharmacology and Therapeutics 21:s2, pages 92-98.
Crossref
Crossref
TAKAFUMI MIHARA, KYOICHI ADACHI, YOSHINORI KOMAZAWA, MANABU YOSHIDA, ASUKA ARAKI, RIRUKE MARUYAMA, KENJI FURUTA, SHUNJI ISHIHARA, YUJI AMANO & YOSHIKAZU KINOSHITA. (2005) Characteristics of gastritis in patients with Helicobacter pylori-positive reflux esophagitis. Journal of Gastroenterology and Hepatology 20:5, pages 682-687.
Crossref
Crossref
Deng-Chyang Wu, I-Chen Wu, Jang-Ming Lee, Hon-Ki Hsu, Ein-Long Kao, Shah-Hwa Chou & Ming-Tsang Wu. (2005) Helicobacter pylori Infection: A Protective Factor for Esophageal Squamous Cell Carcinoma in a Taiwanese Population. The American Journal of Gastroenterology 100:3, pages 588-593.
Crossref
Crossref
José L. Calleja, Manuel Suarez, Alberto Herreros de Tejada & Angel Navarro. (2005) Helicobacter pylori Infection in Patients with Erosive Esophagitis Is Associated with Rapid Heartburn Relief and Lack of Relapse After Treatment with Pantoprazole. Digestive Diseases and Sciences 50:3, pages 432-439.
Crossref
Crossref
Suja DuBois & David J. Kearney. (2005) Iron-Deficiency Anemia and Helicobacter pylori Infection: A Review of the Evidence. The American Journal of Gastroenterology 100:2, pages 453-459.
Crossref
Crossref
J. Pisegna, G. Holtmann, C. W. Howden, P. H. Katelaris, P. Sharma, S Spechler, G. Triadafilopoulos & G. Tytgat. (2004) Review article: oesophageal complications and consequences of persistent gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 20, pages 47-56.
Crossref
Crossref
Saliou Diop, Achille Aouba & Bruno Varet. (2004) Guérison d’une anémie par carence en fer après éradication d’Helicobacter pylori. La Presse Médicale 33:21, pages 1517-1518.
Crossref
Crossref
A. Sonnenberg. (2004) Review article: trials on reflux disease - the role of acid secretion and inhibition. Alimentary Pharmacology & Therapeutics 20, pages 2-8.
Crossref
Crossref
Sefa G??liter & Ugur Kandilci. (2004) The Effect of Helicobacter pylori Eradication on Gastroesophageal Reflux Disease. Journal of Clinical Gastroenterology 38:9, pages 750-755.
Crossref
Crossref
Nimish B. Vakil, Barry M. Traxler & Douglas Levine. (2004) Symptom Response and Healing of Erosive Esophagitis with Proton-Pump Inhibitors in Patients with Helicobacter pylori Infection. The American Journal of Gastroenterology 99:8, pages 1437-1441.
Crossref
Crossref
Byung Ha Jeon, Yoo Joung Oh, Na Gyong Lee & Yon Ho Choe. (2004) Polymorphism of the Helicobacter pylori feoB Gene in Korea: a Possible Relation with Iron-Deficiency Anemia?. Helicobacter 9:4, pages 330-334.
Crossref
Crossref
Yasuhiko Abe, Shuichi Ohara, Tomoyuki Koike, Hitoshi Sekine, Katsunori Iijima, Masashi Kawamura, Akira Imatani, Katsuaki Kato & Tooru Shimosegawa. (2004) The Prevalence of Helicobacter Pylori Infection and the Status of Gastric Acid Secretion in Patients with Barrett's Esophagus in Japan. The American Journal of Gastroenterology 99:7, pages 1213-1221.
Crossref
Crossref
C. Ciacci, F. Sabbatini, R. Cavallaro, F. Castiglione, S. Di Bella, P. Iovino, A. Palumbo, R. Tortora, D. Amoruso & G. Mazzacca. (2004) Helicobacter pylori impairs iron absorption in infected individuals. Digestive and Liver Disease 36:7, pages 455-460.
Crossref
Crossref
K. Iijima, H. Sekine, T. Koike, A. Imatani, S. Ohara & T. Shimosegawa. (2004) Long-term effect of Helicobacter pylori eradication on the reversibility of acid secretion in profound hypochlorhydria. Alimentary Pharmacology & Therapeutics 19:11, pages 1181-1188.
Crossref
Crossref
Benson T. Massey. (2004) The implications of Helicobacter pylori infection for gastroesophageal reflux disease: Studies presented at Digestive Disease Week 2003. Current Gastroenterology Reports 6:3, pages 191-195.
Crossref
Crossref
Limas Kupcinskas, Laimas Jonaitis & Gediminas Kiudelis. (2004) A 1 year follow-up study of the consequences of Helicobacter pylori eradication in duodenal ulcer patients. European Journal of Gastroenterology & Hepatology 16:4, pages 369-374.
Crossref
Crossref
A. T. R. Axon. (2004) Personal view: to treat or not to treat? Helicobacter pylori and gastro-oesophageal reflux disease - an alternative hypothesis. Alimentary Pharmacology & Therapeutics 19:3, pages 253-261.
Crossref
Crossref
Shigemi Nakajima & Takanori Hattori. (2003) Active and Inactive Gastroesophageal Reflux Diseases Related to Helicobacter pylori Therapy. Helicobacter 8:4, pages 279-293.
Crossref
Crossref
YON HO CHOE, YOO JOUNG OH, NA GYONG LEE, ICHIRO IMOTO, YUKIHIKO ADACHI, NAGAHITO TOYODA & ESTEBAN C GABAZZA. (2003) Lactoferrin sequestration and its contribution to iron-deficiency anemia in Helicobacter pylori-infected gastric mucosa. Journal of Gastroenterology and Hepatology 18:8, pages 980-985.
Crossref
Crossref
David Y Graham. (2003) The Changing Epidemiology of Gerd: Geography and Helicobacter Pylori. American Journal of Gastroenterology 98:7, pages 1462-1470.
Crossref
Crossref
A. Sasaki, K. Haruma, N. Manabe, S. Tanaka, M. Yoshihara & K. Chayama. (2003)
Long-term observation of reflux oesophagitis developing after
Helicobacter pylori
eradication therapy
. Alimentary Pharmacology & Therapeutics 17:12, pages 1529-1534.
Crossref
Crossref
TOSHIHIKO HAYAKAWA, HIROSHI KANEKO, TOSHIHIRO KONAGAYA, KAORI SHINOZAKI, AKIHITO KASAHARA, YASUSHI FUNAKI, SHOZABURO MORI, TAKIO YOKOI, YOSHIFUMI HIROOKA, KAZUO KUSUGAMI & SHINICHI KAKUMU. (2003)
Enhanced somatostatin secretion into the gastric juice with recovery of basal acid output after
Helicobacter pylori
eradication in gastric ulcers
. Journal of Gastroenterology and Hepatology 18:5, pages 505-511.
Crossref
Crossref
P. Zentilin, E. Iiritano, C. Vignale, C. Bilardi, M. R. Mele, P. Spaggiari, C. Gambaro, P. Dulbecco, L. Tessieri, S. Reglioni, C. Mansi, L. Mastracci, S. Vigneri, R. Fiocca & V. Savarino. (2003)
Helicobacter pylori
infection is not involved in the pathogenesis of either erosive or non-erosive gastro-oesophageal reflux disease
. Alimentary Pharmacology & Therapeutics 17:8, pages 1057-1064.
Crossref
Crossref
Hashem B El-Serag. (2003) The epidemic of esophageal adenocarcinoma. Hematology/Oncology Clinics of North America 17:2, pages 413-432.
Crossref
Crossref
Maria Kostaki, Smaragdi Fessatou & Themistocles Karpathios. (2003) Refractory iron-deficiency anaemia due to silent Helicobacter pylori gastritis in children. European Journal of Pediatrics 162:3, pages 177-179.
Crossref
Crossref
P. Sharma & N. Vakil. (2003)
Helicobacter pylori
and reflux disease
. Alimentary Pharmacology & Therapeutics 17:3, pages 297-305.
Crossref
Crossref
K. Higuchi, Y. Fujiwara, K. Tominaga, T. Watanabe, M. Shiba, S. Nakamura, N. Oshitani, T. Matsumoto & T. Arakawa. (2003) Is eradication sufficient to heal gastric ulcers in patients infected with Helicobacter pylori? A randomized, controlled, prospective study. Alimentary Pharmacology & Therapeutics 17:1, pages 111-117.
Crossref
Crossref
R. M. Genta. (2002) After gastritis - an imaginary journey into a Helicobacter-free world. Alimentary Pharmacology & Therapeutics 16, pages 89-94.
Crossref
Crossref
Hashem B El-Serag. (2002) The epidemic of esophageal adenocarcinoma. Gastroenterology Clinics of North America 31:2, pages 421-440.
Crossref
Crossref
David Y. Graham. (2002)
Critical Effect of
Helicobacter pylori
Infection on the Effectiveness of Omeprazole for Prevention of Gastric or Duodenal Ulcers Among Chronic NSAID Users
. Helicobacter 7:1, pages 1-8.
Crossref
Crossref
Takashige TOMITA, Nozomi YOSHIKAWA, Fuyuhiko YAMAMURA, Yasushi AKITA, Koji SAITO & Keiji MITAMURA. (2002) Ranitidine and Omeprazole Treatment of Hemorrhagic Gastric Ulcesrs in Patients Positive for H. pylori: Inhibition of Gastric acid Secretion Correlates with Histologic Features. The Showa University Journal of Medical Sciences 14:2, pages 107-115.
Crossref
Crossref
G. Capurso, E. Lahner, A. Marcheggiano, P. Caruana, A. Carnuccio, C. Bordi, G. Delle Fave & B. Annibale. (2001)
Involvement of the corporal mucosa and related changes in gastric acid secretion characterize patients with iron deficiency anaemia associated with
Helicobacter pylori
infection
. Alimentary Pharmacology & Therapeutics 15:11, pages 1753-1761.
Crossref
Crossref
Akiko Shiotani, Shingo Nishioka, Mikitaka Iguchi, Kimihiko Yanaoka, Kazuhisa Okada, Hidyuki Tamai, Yoshihiko Mantani, Hidekazu Itoh & David Y. Graham. (2001) Duodenal erosions after eradication of Helicobacter pylori infection. Gastrointestinal Endoscopy 54:4, pages 448-453.
Crossref
Crossref
Frank Zerbib, Valérie Bicheler, Véronique Leray, Madeleine Joubert, Stanislas Bruley des Varannes & Jean-Paul Galmiche. (2001)
H. pylori
and transient lower esophageal sphincter relaxations induced by gastric distension in healthy humans
. American Journal of Physiology-Gastrointestinal and Liver Physiology 281:2, pages G350-G356.
Crossref
Crossref
T. Koike, S. Ohara, H. Sekine, K. Iijima, K. Kato, T. Toyota & T. Shimosegawa. (2002)
Increased gastric acid secretion after
Helicobacter pylori
eradication may be a factor for developing reflux oesophagitis
. Alimentary Pharmacology & Therapeutics 15:6, pages 813-820.
Crossref
Crossref
M Takashima, T Furuta, H Hanai, H Sugimura & E Kaneko. (2001)
Effects of
Helicobacter pylori
infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils
. Gut 48:6, pages 765-773.
Crossref
Crossref
J. Dent. (2001)
Is
Helicobacter pylori
relevant in the management of reflux disease?
. Alimentary Pharmacology & Therapeutics 15, pages 16-21.
Crossref
Crossref
David Y. Graham & Waqar A. Qureshi. 2001. Helicobacter pylori. Helicobacter pylori
499
510
.
Gabriele Berg, Günter Bode, Maria Blettner, Heiner Boeing & Hermann Brenner. (2001) Helicobacter Pylori Infection and Serum Ferritin: A Population-Based Study Among 1806 Adults in Germany. American Journal of Gastroenterology 96:4, pages 1014-1018.
Crossref
Crossref
Yon Ho Choe, Tae Sook Hwang, Hyun Joo Kim, Seok Hwan Shin, Sun Uk Song & Mi Sook Choi. (2008)
A Possible Relation of the
Helicobacter pylori pfr
Gene to Iron Deficiency Anemia?
. Helicobacter 6:1, pages 55-59.
Crossref
Crossref
István Rácz, Andrea Szabó, Mihály Csöndes, Gyula Pécsi & Mária Goda. (2001) Eradication of Helicobacter pylori has no effect on gastric acidity in duodenal ulcer patients—evaluation of 24-h pH monitoring. Journal of Physiology-Paris 95:1-6, pages 469-475.
Crossref
Crossref
Kiichi Satoh. (2000) Does Eradication of Helicobacter Pylori Reverse Atrophic Gastritis or Intestinal Metaplasia?. Gastroenterology Clinics of North America 29:4, pages 829-835.
Crossref
Crossref
S. Vigneri, R. Termini, V. Savarino & F. Pace. (2000) Is Helicobacter pylori status relevant in the management of GORD?. Alimentary Pharmacology & Therapeutics 14, pages 31-42.
Crossref
Crossref
Akiko Shiotani, Zhannat Z. Nurgalieva, Yoshio Yamaoka & David Y. Graham. (2000) HELICOBACTER PYLORI. Medical Clinics of North America 84:5, pages 1125-1136.
Crossref
Crossref
Hamada, Haruma, Mihara, Kamada, Yoshihara, Sumii, Kajiyama & Kawanishi. (2001)
High incidence of reflux oesophagitis after eradication therapy for
Helicobacter pylori
: impacts of hiatal hernia and corpus gastritis
. Alimentary Pharmacology & Therapeutics 14:6, pages 729-735.
Crossref
Crossref
Wu, Sung, Chan, Ching, Ng, Go, Wong, Ng & Chung. (2001)
Helicobacter pylori
infection is associated with milder gastro‐oesophageal reflux disease
. Alimentary Pharmacology & Therapeutics 14:4, pages 427-432.
Crossref
Crossref
Regina Lamberts. (2000) Morphological changes of the human gastric mucosa under long-term proton pump inhibitor therapy and their clinical relevance. Microscopy Research and Technique 48:6, pages 357-366.
Crossref
Crossref
Ken Haruma, Hiroshige Hamada, Mitsuhiro Mihara, Tomoari Kamada, Masaharu Yoshihara, Koji Sumii, Goro Kajiyama & Masahiro Kawanishi. (2001)
Negative Association Between
Helicobacter pylori
Infection and Reflux Esophagitis in Older Patients: Case‐Control Study in Japan
. Helicobacter 5:1, pages 24-29.
Crossref
Crossref
D. Y. Graham. 2000. Helicobacter pylori. Helicobacter pylori
453
459
.
K. E. L. Mccoll & E. El-Omar. 2000. Helicobacter pylori. Helicobacter pylori
373
384
.
Ryuto Hirasawa, Masaharu Tatsuta, Hiroyasu Iishi, Hiroyuki Yano, Miyako Baba, Noriya Uedo & Noriko Sakai. (1999) Increase in Apoptosis and Decrease in Ornithine Decarboxylase Activity of The Gastric Mucosa in Patients With Atrophic Gastritis and Gastric Ulcer After Successful Eradication of Helicobacter Pylori. American Journal of Gastroenterology 94:9, pages 2398-2402.
Crossref
Crossref
M. A. van Herwaarden, M. Samsom, C. H. M. van Nispen, P. G. H. Mulder & A. J. P. M. Smout. (1999)
The effect of
Helicobacter pylori
eradication on intragastric pH during dosing with lansoprazole or ranitidine
. Alimentary Pharmacology & Therapeutics 13:6, pages 731-740.
Crossref
Crossref
David Y Graham. (1999) Helicobacter pylori , GERD, NSAIDs, and Cancer: Where We Really Stand. American Journal of Gastroenterology 94:5, pages 1420-1421.
Crossref
Crossref
Haruma, Mihara, Okamoto, Kusunoki, Hananoki, Tanaka, Yoshihara, Sumii & Kajiyama. (1999)
Eradication of
Helicobacter pylori
increases gastric acidity in patients with atrophic gastritis of the corpus-evaluation of 24-h pH monitoring
. Alimentary Pharmacology & Therapeutics 13:2, pages 155-162.
Crossref
Crossref
E.J. Kuipers & E.C. Klinkenberg-Knol. (1999) Helicobacter pylori, acid, and omeprazole revisited: Bacterial eradication and rebound hypersecretion. Gastroenterology 116:2, pages 479-483.
Crossref
Crossref
Masaru Yoshida, Yoshio Wakatsuki, Yoshinao Kobayashi, Toshiyuki Itoh, Kazuhisa Murakami, Akira Mizoguchi, Takashi Usui, Tsutomu Chiba & Toru Kita. (1999)
Cloning and Characterization of a Novel Membrane-Associated Antigenic Protein of
Helicobacter pylori
. Infection and Immunity 67:1, pages 286-293.
Crossref
Crossref
Waqar A. Qureshi & David Y. Graham. (1999) Diagnosis and management of Helicobacter pylori infection. Clinical Cornerstone 1:5, pages 18-28.
Crossref
Crossref
David Y. Graham & Yoshio Yamaoka. (2001)
H. pylori
and
cagA
: Relationships with Gastric Cancer, Duodenal Ulcer, and Reflux Esophagitis and Its Complications
. Helicobacter 3:3, pages 145-151.
Crossref
Crossref
David Y. Graham. (1998) Gastrin sensitivity and acid in H. pylori: Revisited. Gastroenterology 115:2, pages 509-510.
Crossref
Crossref
Nils Milman, Steffen Rosenstock, Leif Andersen, Torben Jørgensen & Olaf Bonnevie. (1998) Serum ferritin, hemoglobin, and Helicobacter pylori infection: A seroepidemiologic survey comprising 2794 Danish adults. Gastroenterology 115:2, pages 268-274.
Crossref
Crossref
Mark Feldman, Byron Cryer & Edward Lee. (1998)
Effects of
Helicobacter pylori
gastritis on gastric secretion in healthy human beings
. American Journal of Physiology-Gastrointestinal and Liver Physiology 274:6, pages G1011-G1017.
Crossref
Crossref
Paul D. MullinsHoward W. Steer. (2001)
Helicobacter pylori
Colonization Density and Gastric Acid Output in Non‐ulcer Dyspepsia and Duodenal Ulcer Disease
. Helicobacter 3:2, pages 86-92.
Crossref
Crossref